Parvin Asset Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
16,455
-455
-3% -$43.7K 1.23% 14
2026
Q1
$1.75M Buy
16,910
+880
+5% +$99.8K 1.26% 19
2025
Q4
$1.62M Buy
16,030
+12,370
+338% +$1.34M 1.28% 19
2025
Q3
$451K Buy
3,660
+1,625
+80% +$202K 0.39% 77
2025
Q2
$244K Buy
2,035
+109
+6% +$14.5K 0.25% 98
2025
Q1
$284K Buy
1,926
+186
+11% +$28.4K 0.31% 87
2024
Q4
$283K Buy
+1,740
New +$285K 0.3% 87

Other funds holding CLX

Parvin Asset Management's CLX Position: Q2 2026 in Review

Parvin Asset Management reduced its Clorox (CLX) stake by 2.7% in Q2 2026, selling an estimated $43.7K and leaving 16,455 shares worth $1.57M. The position accounts for 1.23% of the portfolio, ranked #14.

Parvin Asset Management first reported a position in CLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.75M in Q1 2026. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Parvin Asset Management held 16,455 shares of Clorox worth $1.57M as of Q2 2026.
  • Parvin Asset Management sold 455 Clorox shares in Q2 2026, an estimated $43.7K.
  • Clorox made up 1.23% of Parvin Asset Management's portfolio in Q2 2026, its #14 holding.
  • Parvin Asset Management first reported a position in Clorox in Q4 2024 and has held it in 7 quarters since.
  • Parvin Asset Management's Clorox position peaked at $1.75M in Q1 2026.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.